Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Swapnil Patil, S G Gattani, Pradip Nirbhavane, O P Katare & Kiran Patil. (2022) Quality by Design (QbD) driven Systematic Development of Nano-lipoidal Carrier of Poorly Water Soluble Anti-tubercular agent-Rifabutin.. Materials Technology 37:8, pages 695-705.
Read now
Read now
Wenli Zhang, Enshi Hu, Yajie Wang, Si Miao, Yanyan Liu, Yumin Hu$suffix/text()$suffix/text(), Ji Liu, Bohui Xu, Daquan Chen & Yan Shen. (2021) Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment. International Journal of Nanomedicine 16, pages 6141-6156.
Read now
Read now
Tulshidas S. Patil & Ashwini S. Deshpande. (2021) Nanostructured lipid carrier-mediated lung targeted drug delivery system to enhance the safety and bioavailability of clofazimine. Drug Development and Industrial Pharmacy 47:3, pages 385-393.
Read now
Read now
Flavio De Maio, Valentina Palmieri, Marco De Spirito, Giovanni Delogu & Massimiliano Papi. (2019) Carbon nanomaterials: a new way against tuberculosis. Expert Review of Medical Devices 16:10, pages 863-875.
Read now
Read now
Marina Pinheiro, Ricardo Ribeiro, Alexandre Vieira, Fernanda Andrade & Salette Reis. (2016) Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis. Drug Design, Development and Therapy 10, pages 2467-2475.
Read now
Read now
Jagdeep Singh, Tarun Garg, Goutam Rath & Amit K. Goyal. (2016) Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review. Drug Delivery 23:5, pages 1676-1698.
Read now
Read now
Wing-Hin Lee, Ching-Yee Loo, Daniela Traini & Paul M Young. (2015) Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opinion on Drug Delivery 12:6, pages 1009-1026.
Read now
Read now
John Gar Yan Chan, Xiaoxue Bai & Daniela Traini. (2014) An update on the use of rifapentine for tuberculosis therapy. Expert Opinion on Drug Delivery 11:3, pages 421-431.
Read now
Read now
Swati Gupta, Abhinav Agarwal, Nishant Kumar Gupta, Gauravkant Saraogi, Himanshu Agrawal & G. P Agrawal. (2013) Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir. Drug Development and Industrial Pharmacy 39:12, pages 1866-1873.
Read now
Read now
Hugo Costa & Ana Grenha. (2013) Natural carriers for application in tuberculosis treatment. Journal of Microencapsulation 30:3, pages 295-306.
Read now
Read now
Narendra K Jain, Vijay Mishra & Neelesh Kumar Mehra. (2013) Targeted drug delivery to macrophages. Expert Opinion on Drug Delivery 10:3, pages 353-367.
Read now
Read now
Pankaj Dwivedi, Shaswat Kansal, Monika Sharma, Rahul Shukla, Ashwini Verma, Prashant Shukla, Priyanka Tripathi, Pramod Gupta, Deepika Saini, Kiran Khandelwal, Rahul Verma, Anil Kumar Dwivedi & Prabhat Ranjan Mishra. (2012) Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo. Journal of Drug Targeting 20:10, pages 883-896.
Read now
Read now
Beatriz Lasa-Saracibar, Ander Estella-Hermoso de Mendoza, Melissa Guada, Carmen Dios-Vieitez & María J Blanco-Prieto. (2012) Lipid nanoparticles for cancer therapy: state of the art and future prospects. Expert Opinion on Drug Delivery 9:10, pages 1245-1261.
Read now
Read now
Amit Rathore, Ashish Jain, Arvind Gulbake, Satish Shilpi, Piush Khare, Aviral Jain & Sanjay K. Jain. (2011) Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis. Journal of Liposome Research 21:4, pages 333-340.
Read now
Read now
Gaurav Kant Saraogi, Bhavna Sharma, Beenu Joshi, Pushpa Gupta, Umesh Dutta Gupta, Narendra Kumar Jain & Govind Prasad Agrawal. (2011) Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis. Journal of Drug Targeting 19:3, pages 219-227.
Read now
Read now
Articles from other publishers (85)
Ali Razei, Mohammad Javanbakht, Abbas Hajizade, Mohammad Heiat, Shi Zhao, Hossien Aghamollaei, Mojtaba Saadati, Mostafa Khafaei, Mosa Asadi, Luca Cegolon & Amir Homayoun Keihan. (2023) Nano and microparticle drug delivery systems for the treatment of Brucella infections. Biomedicine & Pharmacotherapy 169, pages 115875.
Crossref
Crossref
Qinghan Tang, Mei Dong, Zeyu Xu, Nannan Xue, Ruihan Jiang, Xuchao Wei, Jingyue Gu, Yue Li, Rongshuang Xin, Jia Wang, Xueying Xiao, Xin Zhou, Shaoping Yin, Yiwei Wang & Jun Chen. (2023) Red blood cell-mimicking liposomes loading curcumin promote diabetic wound healing. Journal of Controlled Release 361, pages 871-884.
Crossref
Crossref
Jayoung Chae, Seung Hyun Kang, Jiwon Kim, Yonghyun Choi, Shin Hyuk Kang & Jonghoon Choi. (2023)
Targeted and efficient delivery of rifampicin to macrophages involved in non-tuberculous mycobacterial infection
via
mannosylated solid lipid nanoparticles
. Nanoscale Advances 5:17, pages 4536-4545.
Crossref
Crossref
Qinqin Fei, Emily M. Shalosky, Ryelie Barnes, Vasudha C. Shukla, Siying Xu, Megan N. Ballinger, Laszlo Farkas, Robert J. Lee, Samir N. Ghadiali & Joshua A. Englert. (2023) Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome. ACS Nano.
Crossref
Crossref
Sandra Robla, Rubén Varela Calviño, Rita Ambrus & Noemi Csaba. (2023) A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery. European Journal of Pharmaceutical Sciences 185, pages 106442.
Crossref
Crossref
Jingxuan Cui, Chengyu Zhang, Hongliang Liu, Lijun Yang, Xiao Liu, Jingjing Zhang, Ying Zhou, Junhua Zhang & Xiaohui Yan. (2023) Pulmonary Delivery of Recombinant Human Bleomycin Hydrolase Using Mannose-Modified Hierarchically Porous UiO-66 for Preventing Bleomycin-Induced Pulmonary Fibrosis. ACS Applied Materials & Interfaces 15:9, pages 11520-11535.
Crossref
Crossref
Igor D. Zlotnikov, Alexander A. Ezhov, Maksim A. Vigovskiy, Olga A. Grigorieva, Uliana D. Dyachkova, Natalia G. Belogurova & Elena V. Kudryashova. (2023) Application Prospects of FTIR Spectroscopy and CLSM to Monitor the Drugs Interaction with Bacteria Cells Localized in Macrophages for Diagnosis and Treatment Control of Respiratory Diseases. Diagnostics 13:4, pages 698.
Crossref
Crossref
Venkata Deepthi Vemuri, Rekharani Kushwaha, Gollu Gowri, Nalini Mathala, Swathi Nalla, Sasikala Allam & Gurijala Lekhya. (2023) An Overview on Macrophage Targeting: A Promising Approach. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:5, pages 47-92.
Crossref
Crossref
Vidyadevi Bhoyar, Sagar Trivedi, Shreyas Gaikwad, Aarti Belgamwar & Veena Belgamwar. 2023. Nanotechnology Principles in Drug Targeting and Diagnosis. Nanotechnology Principles in Drug Targeting and Diagnosis
269
300
.
Igor D. Zlotnikov, Maksim A. Vigovskiy, Maria P. Davydova, Milan R. Danilov, Uliana D. Dyachkova, Olga A. Grigorieva & Elena V. Kudryashova. (2022) Mannosylated Systems for Targeted Delivery of Antibacterial Drugs to Activated Macrophages. International Journal of Molecular Sciences 23:24, pages 16144.
Crossref
Crossref
Pratiksha Prabhu, Trinette Fernandes, Mansi Damani, Pramila Chaubey, Shridhar Narayanan & Sujata Sawarkar. (2022) 2 Receptor Specific Ligand Conjugated Nanocarriers: An Effective Strategy
for Targeted Therapy of Tuberculosis. Current Drug Delivery 19:8, pages 830-845.
Crossref
Crossref
Maharshi Thalla, Gangipangi Vijayakumar, Sudhagar Selvaraju & Subham Banerjee. (2022) Pharmacoengineered Lipid Core–Shell Nanoarchitectonics to Influence Human Alveolar Macrophages Uptake for Drug Targeting Against Tuberculosis. Journal of Inorganic and Organometallic Polymers and Materials 32:9, pages 3276-3291.
Crossref
Crossref
Anirudh Gairola, Aaron Benjamin, Joshua D. Weatherston, Jeffrey D. Cirillo & Hung‐Jen Wu. (2022) Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages. Advanced Therapeutics 5:6.
Crossref
Crossref
Donglin Cai, Wendong Gao, Zhelun Li, Yufeng Zhang, Lan Xiao & Yin Xiao. (2022) Current Development of Nano-Drug Delivery to Target Macrophages. Biomedicines 10:5, pages 1203.
Crossref
Crossref
Igor D. Zlotnikov & Elena V. Kudryashova. (2022) Spectroscopy Approach for Highly-Efficient Screening of Lectin-Ligand Interactions in Application for Mannose Receptor and Molecular Containers for Antibacterial Drugs. Pharmaceuticals 15:5, pages 625.
Crossref
Crossref
Jana Ghitman, Gratiela Gradisteanu Pircalabioru, Adriana Zainea, Luminita Marutescu, Horia Iovu, Eugeniu Vasile, Cristina Stavarache, Bogdan Stefan Vasile & Raluca Stan. (2022) Macrophage-targeted mannose-decorated PLGA-vegetable oil hybrid nanoparticles loaded with anti-inflammatory agents. Colloids and Surfaces B: Biointerfaces 213, pages 112423.
Crossref
Crossref
Shamama Javed, Bharti Mangla, Yosif Almoshari, Muhammad H. Sultan & Waquar Ahsan. (2022) Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews 11:1, pages 1744-1777.
Crossref
Crossref
Pratik Kakade, Arkasubhro Chatterjee, Anjali Pandya, John Disouza & Vandana Patravale. (2022) Carbohydrate anchored lipid nanoparticles. International Journal of Pharmaceutics 618, pages 121681.
Crossref
Crossref
Merve Karpuz & Mine Silindir‐Gunay. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
469
503
.
Maharshi Thalla & Subham Banerjee. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
371
410
.
I. D. Zlotnikov & E. V. Kudryashova. (2022) Mannose Receptors of Alveolar Macrophages as a Target for the Addressed Delivery of Medicines to the Lungs. Russian Journal of Bioorganic Chemistry 48:1, pages 46-75.
Crossref
Crossref
Amir Ajoolabady, Yaguang Bi, David J. McClements, Gregory Y.H. Lip, Des R. Richardson, Russel J. Reiter, Daniel J. Klionsky & Jun Ren. (2022) Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy. Pharmacological Research 176, pages 106072.
Crossref
Crossref
И.Д. Злотников & Е.В. Кудряшова. (2022) Компьютерное моделирование лиганд-рецепторных взаимодействий маннозного рецептора CD206 в сравнении с модельным лектином конканавалином А. Биохимия 87:1, pages 68-85.
Crossref
Crossref
Igor D. Zlotnikov & Elena V. Kudryashova. (2022) Computer simulation of the Receptor–Ligand Interactions of Mannose Receptor CD206 in Comparison with the Lectin Concanavalin A Model. Biochemistry (Moscow) 87:1, pages 54-69.
Crossref
Crossref
Ankita Tiwari, Anamika Sahu Gulbake & Pramod Kumar. 2022. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases
229
273
.
Deny Susanti, Nurul I. Aminudin, Mohamad W. Ismail, Muhammad Taher, Saiful A. Shafiee, Wan H. Danial & Nurasyikin Hamzah. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance
365
394
.
Pooja Sanjay Khairnar, Ajit Singh & Rahul Shukla. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases
387
417
.
Taraj Vyas, Srividya Gorantla, Tejashree Waghule, Vamshi Krishna Rapalli & Gautam Singhvi. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
259
280
.
Nawras Osman, Nikita Devnarain, Calvin A. Omolo, Victoria Fasiku, Yajna Jaglal & Thirumala Govender. (2021) Surface modification of nano‐drug delivery systems for enhancing antibiotic delivery and activity. WIREs Nanomedicine and Nanobiotechnology 14:1.
Crossref
Crossref
Ahmed A. H. Abdellatif, Hamdoon A. Mohammed, Riaz A. Khan, Varsha Singh, Abdellatif Bouazzaoui, Mohammad Yusuf, Naseem Akhtar, Maria Khan, Amal Al-Subaiyel, Salman A. A. Mohammed & Mohsen S. Al-Omar. (2021) Nano-scale delivery: A comprehensive review of nano-structured devices, preparative techniques, site-specificity designs, biomedical applications, commercial products, and references to safety, cellular uptake, and organ toxicity. Nanotechnology Reviews 10:1, pages 1493-1559.
Crossref
Crossref
Wataru Kawase, Daisuke Kurotaki, Yuta Suzuki, Hiroshi Ishihara, Tatsuma Ban, Go R. Sato, Juri Ichikawa, Hideyuki Yanai, Tadatsugu Taniguchi, Kappei Tsukahara & Tomohiko Tamura. (2021) Irf5 siRNA-loaded biodegradable lipid nanoparticles ameliorate concanavalin A-induced liver injury. Molecular Therapy - Nucleic Acids 25, pages 708-715.
Crossref
Crossref
Lide Arana, Lucia Gallego & Itziar Alkorta. (2021) Incorporation of Antibiotics into Solid Lipid Nanoparticles: A Promising Approach to Reduce Antibiotic Resistance Emergence. Nanomaterials 11:5, pages 1251.
Crossref
Crossref
Nimitt V. Chokshi, Shruti Rawal, Dhruvi Solanki, Saumitra Gajjar, Vivek Bora, Bhoomika M. Patel & Mayur M. Patel. (2021) Fabrication and Characterization of Surface Engineered Rifampicin Loaded Lipid Nanoparticulate Systems for the Potential Treatment of Tuberculosis: An In Vitro and In Vivo Evaluation. Journal of Pharmaceutical Sciences 110:5, pages 2221-2232.
Crossref
Crossref
Aldemar Gordillo-Galeano, Luis Fernando Ospina-Giraldo & Claudia Elizabeth Mora-Huertas. (2021) Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment. International Journal of Pharmaceutics 596, pages 120321.
Crossref
Crossref
Sivaraj Mehnath & Murugaraj Jeyaraj. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
59
89
.
Tamim Mosaiab, Dylan C. Farr, Milton J. Kiefel & Todd A. Houston. 2021. Comprehensive Glycoscience. Comprehensive Glycoscience
406
432
.
Zsuzsa Baranyai, Héctor Soria‐Carrera, Maria Alleva, Ana C. Millán‐Placer, Ainhoa Lucía, Rafael Martín‐Rapún, José A. Aínsa & Jesús M. la Fuente. (2020) Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis. Advanced Therapeutics 4:1, pages 2000113.
Crossref
Crossref
Raquel G. D. Andrade, Bruno Reis, Benjamin Costas, Sofia A. Costa Lima & Salette Reis. (2020) Modulation of Macrophages M1/M2 Polarization Using Carbohydrate-Functionalized Polymeric Nanoparticles. Polymers 13:1, pages 88.
Crossref
Crossref
K.D. Patil, S.B. Bagade & S.C. Bonde. (2020) In-vitro and ex-vivo characterization of novel mannosylated gelatin nanoparticles of linezolid by quality-by-design approach. Journal of Drug Delivery Science and Technology 60, pages 101976.
Crossref
Crossref
Helal F Hetta, Esraa A Ahmed, Ahmed G Hemdan, Heba EM El-Deek, Saida Abd-Elregal & Noura H Abd Ellah. (2020) Modulation of rifampicin-induced hepatotoxicity using poly(lactic-co-glycolic acid) nanoparticles: a study on rat and cell culture models. Nanomedicine 15:14, pages 1375-1390.
Crossref
Crossref
Tulshidas S. Patil & Ashwini S. Deshpande. (2020) Mannosylated nanocarriers mediated site-specific drug delivery for the treatment of cancer and other infectious diseases: A state of the art review. Journal of Controlled Release 320, pages 239-252.
Crossref
Crossref
Bibhash Chandra Mohanta, Subas Chandra Dinda, Narahari Narayan Palei & Jyotirmoy Deb. 2020. Role of Novel Drug Delivery Vehicles in Nanobiomedicine. Role of Novel Drug Delivery Vehicles in Nanobiomedicine.
Damián Eduardo Pérez-Martínez & Roberto Zenteno-Cuevas. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
37
52
.
Abdel Naser Dakkah, Yazan Bataineh, Bilal A Al Jaidi, Mohammad F. Bayan & Nabil A. Nimer. 2020. Integrative Nanomedicine for New Therapies. Integrative Nanomedicine for New Therapies
357
404
.
Tamim Mosaiab, Dylan C. Farr, Milton J. Kiefel & Todd A. Houston. (2019) Carbohydrate-based nanocarriers and their application to target macrophages and deliver antimicrobial agents. Advanced Drug Delivery Reviews 151-152, pages 94-129.
Crossref
Crossref
Natasa Gaspar, Giorgia Zambito, Clemens M.W.G. Löwik & Laura Mezzanotte. (2019) Active Nano-targeting of Macrophages. Current Pharmaceutical Design 25:17, pages 1951-1961.
Crossref
Crossref
Akhand Pratap Singh, Arpan Biswas, Aparna Shukla & Pralay Maiti. (2019) Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduction and Targeted Therapy 4:1.
Crossref
Crossref
Prasad Minakshi, Mayukh Ghosh, Basanti Brar, Rajesh Kumar, Upendra P. Lambe, Koushlesh Ranjan, Jinu Manoj & Gaya Prasad. (2019) Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance. Current Pharmaceutical Design 25:13, pages 1554-1579.
Crossref
Crossref
Amira Hamed, Rihab Osman, Khuloud T. Al-Jamal, Samar Mansour Holayel & Ahmed-Shawky Geneidi. (2019) Enhanced antitubercular activity, alveolar deposition and macrophages uptake of mannosylated stable nanoliposomes. Journal of Drug Delivery Science and Technology 51, pages 513-523.
Crossref
Crossref
Meenu Mehta, Deeksha, Neha Sharma, Manish Vyas, Navneet Khurana, Pawan Kumar Maurya, Harjeet Singh, Terezinha Pinto Andreoli de Jesus, Harish Dureja, Dinesh Kumar Chellappan, Gaurav Gupta, Ridhima Wadhwa, Trudi Collet, Philip M Hansbro, Kamal Dua & Saurabh Satija. (2019) Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases. Chemico-Biological Interactions 304, pages 10-19.
Crossref
Crossref
Eleonora Maretti, Luca Costantino, Francesca Buttini, Cecilia Rustichelli, Eliana Leo, Eleonora Truzzi & Valentina Iannuccelli. (2018) Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy. Drug Delivery and Translational Research 9:1, pages 298-310.
Crossref
Crossref
Luminiţa Măruţescu, Diana Frăţiean & Mariana Carmen Chifiriuc. 2019. Nanomaterials for Drug Delivery and Therapy. Nanomaterials for Drug Delivery and Therapy
245
266
.
Viswanathan A. Aparna, Raja Biswas & R. Jayakumar. 2019. Biomimetic Nanoengineered Materials for Advanced Drug Delivery. Biomimetic Nanoengineered Materials for Advanced Drug Delivery
169
185
.
Subham Banerjee & Subhadeep Roy. 2019. Polysaccharide Carriers for Drug Delivery. Polysaccharide Carriers for Drug Delivery
397
411
.
Priyanka Jahagirdar, Amit S. Lokhande, Prajakta Dandekar & Padma V. Devarajan. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
433
456
.
Diana P. Gaspar & António J. Almeida. 2019. Surface Modification of Nanoparticles for Targeted Drug Delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery
73
98
.
Vivek Viswanathan, Heta Mehta, Rajesh Pharande, Anilkumar Bannalikar, Pushpa Gupta, Umesh Gupta & Alka Mukne. (2018) Mannosylated gelatin nanoparticles of licorice for use in tuberculosis: Formulation, in vitro evaluation, in vitro cell uptake, in vivo pharmacokinetics and in vivo anti-tubercular efficacy. Journal of Drug Delivery Science and Technology 45, pages 255-263.
Crossref
Crossref
Lyubov Yu. Filatova, Natalia L. Klyachko & Elena V. Kudryashova. (2018) Targeted delivery of anti-tuberculosis drugs to macrophages: targeting mannose receptors. Russian Chemical Reviews 87:4, pages 374-391.
Crossref
Crossref
Ana Costa, Bruno Sarmento & Vítor Seabra. (2018) Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages. European Journal of Pharmaceutical Sciences 114, pages 103-113.
Crossref
Crossref
Kiran Patil, Shashikant Bagade, Smita Bonde, Sanjay Sharma & Gaurav Saraogi. (2018) Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities. Biomedicine & Pharmacotherapy 99, pages 735-745.
Crossref
Crossref
Eveline Torfs, Jure Vajs, Maíra Bidart de Macedo, Freya Cools, Bieke Vanhoutte, Yury Gorbanev, Annemie Bogaerts, Luc Verschaeve, Guy Caljon, Louis Maes, Peter Delputte, Paul Cos, Janez Košmrlj & Davie Cappoen. (2017) Synthesis and in vitro investigation of halogenated 1,3‐bis(4‐nitrophenyl)triazenide salts as antitubercular compounds. Chemical Biology & Drug Design 91:2, pages 631-640.
Crossref
Crossref
Rajendran Amarnath Praphakar, Harshavardhan Shakila, Vijayan N. Azger Dusthackeer, Murugan A. Munusamy, Suresh Kumar & Mariappan Rajan. (2018) A mannose-conjugated multi-layered polymeric nanocarrier system for controlled and targeted release on alveolar macrophages. Polymer Chemistry 9:5, pages 656-667.
Crossref
Crossref
Eleonora Maretti, Luca Costantino, Cecilia Rustichelli, Eliana Leo, Maria Antonietta Croce, Francesca Buttini, Eleonora Truzzi & Valentina Iannuccelli. (2017) Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α- d -mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy. International Journal of Pharmaceutics 528:1-2, pages 440-451.
Crossref
Crossref
Pradip Nirbhavane, Nalini Vemuri, Neeraj Kumar & Gopal Krishan Khuller. (2016) Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin. AAPS PharmSciTech 18:3, pages 829-837.
Crossref
Crossref
Rajendran Amarnath Praphakar, Murugan A. Munusamy, Abdullah A. Alarfaj, S. Suresh Kumar & Mariappan Rajan. (2017)
Zn
2+
cross-linked sodium alginate-g-allylamine-mannose polymeric carrier of rifampicin for macrophage targeting tuberculosis nanotherapy
. New Journal of Chemistry 41:19, pages 11324-11334.
Crossref
Crossref
Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya & Neelesh K. Mehra. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
293
324
.
Namrata Soni, Neetu Soni, Himanshu Pandey, Rahul Maheshwari, Prashant Kesharwani & Rakesh Kumar Tekade. (2016) Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles. Journal of Colloid and Interface Science 481, pages 107-116.
Crossref
Crossref
Yihua Pei & Yoon Yeo. (2016) Drug delivery to macrophages: Challenges and opportunities. Journal of Controlled Release 240, pages 202-211.
Crossref
Crossref
Jingxing Si, Shiqun Shao, Youqing Shen & Kai Wang. (2016) Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy. Small 12:37, pages 5108-5119.
Crossref
Crossref
Ana Costa, Marina Pinheiro, Joana Magalhães, Ricardo Ribeiro, Vitor Seabra, Salette Reis & Bruno Sarmento. (2016) The formulation of nanomedicines for treating tuberculosis. Advanced Drug Delivery Reviews 102, pages 102-115.
Crossref
Crossref
Ludmylla Cunha & Ana Grenha. (2016) Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications. Marine Drugs 14:3, pages 42.
Crossref
Crossref
Priyanka Tripathi, Pankaj Dwivedi, Renuka Khatik, Anil Kumar Jaiswal, Anuradha Dube, Poonam Shukla & Prabhat Ranjan Mishra. (2015) Development of 4-sulfated N -acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis. Colloids and Surfaces B: Biointerfaces 136, pages 150-159.
Crossref
Crossref
Nityananda Sahoo, Ranjan Ku. Sahoo, Nikhil Biswas, Arijit Guha & Ketousetuo Kuotsu. (2015) Recent advancement of gelatin nanoparticles in drug and vaccine delivery. International Journal of Biological Macromolecules 81, pages 317-331.
Crossref
Crossref
Padma V. Devarajan, Shilpa M. Dawre & Rinku Dutta. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design
113
148
.
Nivrati Jain, Vaibhav Rajoriya, Prateek Kumar Jain & Ashish Kumar Jain. (2013) Lactosaminated-N-succinyl chitosan nanoparticles for hepatocyte-targeted delivery of acyclovir. Journal of Nanoparticle Research 16:1.
Crossref
Crossref
Ahmed O. Elzoghby. (2013) Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research. Journal of Controlled Release 172:3, pages 1075-1091.
Crossref
Crossref
Shelza Banyal, Parth Malik, Hardeep S. Tuli & Tapan K. Mukherjee. (2013) Advances in nanotechnology for diagnosis and treatment of tuberculosis. Current Opinion in Pulmonary Medicine 19:3, pages 289-297.
Crossref
Crossref
Swati Gupta & Pankaj Kumar. (2012) Drug Delivery Using Nanocarriers: Indian Perspective. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 82:S1, pages 167-206.
Crossref
Crossref
Deepak Singodia, Ashwni Verma, Rahul K. Verma & Prabhat Ranjan Mishra. (2012) Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 8:4, pages 468-477.
Crossref
Crossref
Shardool Jain & Mansoor Amiji. 2012. Multifunctional Nanoparticles for Drug Delivery Applications. Multifunctional Nanoparticles for Drug Delivery Applications
47
83
.
Julie Todoroff & Rita Vanbever. (2011) Fate of nanomedicines in the lungs. Current Opinion in Colloid & Interface Science 16:3, pages 246-254.
Crossref
Crossref
Vinod Prabhu, Siddik Uzzaman, Viswanathan Mariammal Berlin Grace & Chandrasekharan Guruvayoorappan. (2011) Nanoparticles in Drug Delivery and Cancer Therapy: The Giant Rats Tail. Journal of Cancer Therapy 02:03, pages 325-334.
Crossref
Crossref
Carlotta Marianecci, Luisa Di Marzio, Federica Rinaldi, Maria Carafa & Franco Alhaique. (2011) Pulmonary Delivery: Innovative Approaches and Perspectives. Journal of Biomaterials and Nanobiotechnology 02:05, pages 567-575.
Crossref
Crossref
Lisa M. Kaminskas & Ben J. Boyd. 2011. Intracellular Delivery. Intracellular Delivery
155
178
.
Himanshu Bhattacharjee, Pavan Balabathula & George C Wood. (2010) Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review. Therapeutic Delivery 1:5, pages 713-734.
Crossref
Crossref